ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

ジピベフリン

Dipivefrin

HCID 3105
ノート反応
基本情報概要名称と識別子物性化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
52365-63-6
標準SMILES
CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
InChIKey
OCUJLLGVOUDECM-UHFFFAOYSA-N
分子式
C19H29NO5
平均分子量
351.4 g/mol
単同位体質量
351.20457303

概要

Dipivefrin is the dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension. It has a role as a sympathomimetic agent, an adrenergic agonist, an antiglaucoma drug, a prodrug and an ophthalmology drug. It is a member of ethanolamines and a pivalate ester. It is functionally related to an adrenaline. It is a conjugate base of a dipivefrin(1+).

名称と識別子

優先名称
Dipivefrin
IUPAC
[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate
現地名
ジピベフリン
英語名
Dipivefrine
分子式
C19H29NO5
分子量
351.44

名称と別名

dipivefrinDipivefrine52365-63-6DipivefrinumDipivefrinadipivalyl epinephrine8Q1PVL543G1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanolCHEBI:4646DTXSID10485444-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate2-[(2,2-dimethylpropanoyl)oxy]-4-[1-hydroxy-2-(methylamino)ethyl]phenyl 2,2-dimethylpropanoate
名称をさらに表示
ジピベフリンrac-4-[(R*)-1-ヒドロキシ-2-(メチルアミノ)エチル]-1,2-フェニレンビス(2,2-ジメチルプロパノアート)(±)-ジピベフリンビスピバル酸4-[1-ヒドロキシ-2-(メチルアミノ)エチル]-1,2-フェニレン2-[(2,2-ジメチルプロパノイル)オキシ]-4-[1-ヒドロキシ-2-(メチルアミノ)エチル]フェニル 2,2-ジメチルプロパノアートK30081K 30081K-30081dipiverfrinDipivefrine-d3Dipivefrine USP/EP/BP
Propanoic acid, 2,2-dimethyl-, 4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylene ester, (+-)-(+-)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate4-(1-hydroxy-2-(methylamino)ethyl)-o-phenylene divavalateDiopineGlaudrops(+-)-4-(1-hydroxy-2-(methylamino)ethyl)-o-phenylene divavalate2-((2,2-dimethylpropanoyl)oxy)-4-(1-hydroxy-2-(methylamino)ethyl)phenyl 2,2-dimethylpropanoate2-((2,2-dimethylpropanoyl)oxy)-5-(1-hydroxy-2-(methylamino)ethyl)phenyl 2,2-dimethylpropanoate

物性

構造計算による物性

XLogP
2.9
極性表面積
84.9 Ų
水素結合供与体数
2
水素結合受容体数
6
回転可能結合数
9
重原子数
25
形式電荷
0
複雑度
463

実験および物理化学的性質

LogP1.7
Solubility · 2 件

Freely soluble as HCl salt

5.82e-02 g/L

Melting Point146-147
Physical DescriptionSolid

物理化学的性質

融点
146 · 146-147°
酸解離定数(Pka)
8.4 · pKa 8.40(RT) (Uncertain)

化学と産業

薬理情報

ATC Code · 2 件

S - Sensory organs

QS - Sensory organs

Pharmacodynamics · 1 件

Dipivefrin is a member of a class of drugs known as prodrugs. Prodrugs are usually not active in themselves and require biotransformation to the parent compound before therapeutic activity is seen. These modifications are undertaken to enhance absorption, decrease side effects and enhance stability and comfort, thus making the parent compound a more useful drug. Enhanced absorption makes the prodrug a more efficient delivery system for the parent drug because less drug will be needed to produce the desired therapeutic response. Dipivefrin is a prodrug of epinephrine formed by the diesterification of epinephrine and pivalic acid. The addition of pivaloyl groups to the epinephrine molecule enhances its lipophilic character and, as a consequence, its penetration into the anterior chamber.

Mechanism of Action · 1 件

Dipivefrin is a prodrug with little or no pharmacologically activity until it is hydrolyzed into epinephrine inside the human eye. The liberated epinephrine, an adrenergic agonist, appears to exert its action by stimulating α -and/or β<sub>2</sub>-adrenergic receptors, leading to a decrease in aqueous production and an enhancement of outflow facility. The dipivefrin prodrug delivery system is a more efficient way of delivering the therapeutic effects of epinephrine, with fewer side effects than are associated with conventional epinephrine therapy.

Metabolism/MetabolitesDipivefrin is converted to epinephrine inside the human eye by enzyme hydrolysis.
FDA Pharmacological Classification · 5 件

8Q1PVL543G

DIPIVEFRIN

Mechanisms of Action [MoA] - Adrenergic Agonists

Established Pharmacologic Class [EPC] - Adrenergic Receptor Agonist

Dipivefrin is an Adrenergic Receptor Agonist. The mechanism of action of dipivefrin is as an Adrenergic Agonist.

MeSH Pharmacological ClassificationDrugs that bind to and activate adrenergic receptors.

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性化学と産業関連反応化合物ノート

データベース識別子

CAS
52365-63-6
PubChem CID
3105
DTXSID
DTXSID1048544
ChEMBL
CHEMBL1201262
ChEBI
CHEBI:4646
UNII
8Q1PVL543G
Nikkaji
J2.819.745D
Absorption, Distribution and Excretion
Well absorbed following occular administration.
Cellular LocationsCytoplasm
応用分野 · 2 件

使用Adrenergic (ophthalmic).

一般的な説明Toovercome several of the pharmacokinetic and pharmaceuticalshortcomings of E as an ophthalmic agent, the prodrugapproach has been successfully applied. Dipivefrin is a prodrugof E that is formed by the esterification of the catecholOH groups of E with pivalic acid. Most of the advantages ofthis prodrug over E stem from improved bioavailability. Thegreatly increased lipophilicity allows much greater penetrabilityinto the eye through the corneal epithelial andendothelial layer. The stroma in between requires hydrophilicityfor penetration. Dipivefrin has that, too, due tothe 1-OH group and cationic nitrogen (the eyedrops containthe hydrochloride [HCl] salt). This dual solubility permitsmuch greater penetrability into the eye than the very hydrophilicE hydrochloride. Increased DOA is also achievedbecause the drug is resistant to the metabolism by COMT.In addition to its increased in vivo stability, it is also lesseasily oxidized by air due to the protection of the catecholOH groups. This high bioavailability and in vivo and in vitrostability translate into increased potency such that the 0.1%ophthalmic solution is approximately equivalent to a 2% Esolution. After its absorption, it is converted to E by esterasesslowly in the cornea and anterior chamber.Dipivefrin also offers the advantage of being less irritatingto the eye than E.

上流・下流製品情報

上流原料

ω,4'-ジヒドロキシアセトフェノン水素ピバロイルクロリドメチルアミン4-(クロロアセチル)カテコール

サプライヤー15 社

杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
Aladdin Scientific[email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
南通全益生物科技有限公司0513-66337626 18051384581 · [email protected]
陕西缔都医药化工有限公司+86-29-81139210 +86-17392587031 · [email protected]
深圳市创鑫生物科技有限公司13417589054 · [email protected]
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
上海芮珊医药科技有限公司02150565560; 17321237488 · [email protected]
BOC Sciences[email protected]
海蔚化学86-21-51086038 · [email protected]
深圳市创鑫生物科技有限公司13417589054 · [email protected]
TargetMol中国(陶术生物)15002134094 · [email protected]
淄博航宇生物科技发展有限公司+86-0533-2185556 +86-15965530500 · [email protected]